Ketamine for MS Fatigue

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

May 5, 2025

Study Completion Date

May 5, 2025

Conditions

Multiple Sclerosis

Interventions

DRUG

ketamine

60mg (.5mg/kg over 40 minutes intravenously)

Trial Locations (1)

Alta Bates Summit Medical Center, Berkeley

All Listed Sponsors

lead

Alta Bates Summit Medical Center

OTHER

NCT06064162 - Ketamine for MS Fatigue | Biotech Hunter | Biotech Hunter